Metropolis Healthcare Limited establishes Innovation Cell to focus on Molecular Genomics, Superspeciality Pathology & Companion Diagnostics
Metropolis Healthcare Limited establishes Innovation Cell to focus on Molecular Genomics, Superspeciality Pathology & Companion Diagnostics
~Introduces specialised tests for Non-Invasive Genetic Assessments for Pregnancy Management that can aid in early detection of chromosomal abnormalities~
~ Launches BRCA1/BRCA 2 Genetic testing for Hereditary Breast and Ovarian Cancer (HBOC), and Molecular Oncology pipeline for Lung and common cancers~
India, Chennai, 7th July 2022: In keeping with its commitment to ensure access to high quality, advanced, and cost-effective diagnostic testing for all, Metropolis Healthcare Ltd. a leading diagnostic service provider today announced the launch of Metropolis Innovation Cell focusing on Molecular Genomics, Superspeciality Patholo gy and Compa...







